Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal MTF for Asthma
NCT02192736Phase 2Terminated
- Sponsor
- Translational Biosciences
- Start
- Jul 2014
- Primary completion
- May 2024
- Modality
- Recombinant Proteins and Enzymes, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal trophic factor in asthma, sponsored by Translational Biosciences. Started Jul 2014; status: terminated.
02
Drugs
mesenchymal trophic factor
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02192736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02192736.